LFCR

Lifecore Biomedical Inc

6.54

-0.07-1.06%

After Hours: 6.63 +0.09 +1.38%18:48 03/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE6.63/6.61

TODAY RANGE6.43-6.71

VOL199.96K

MARKET CAP245.03M

52 WEEK RANGE4.760-8.98

AVG VOL (3M)146.43K

% TURNOVER0.53%

TURNOVER--

P/E (TTM)-5.1334

% RANGE4.31%

EPS(TTM)-1.2740

P/E(FORWARD)-13.9149

P/B5.10

BVPS1.281

DIVIDEND--

P/S1.879

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP240.02M

SHARES OUTSTANDING37.47M

NEXT EARNINGS04/01-04/06

FREE FLOAT36.70M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·3d ago
Lifecore Biomedical to participate in KeyBanc Capital Markets Healthcare Virtual Forum
TipRanks·03/05 22:15
Lifecore Sets 2026 Annual Meeting, Proposal Deadlines
TipRanks·03/05 16:50
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Compass Therapeutics (CMPX) and Shattuck Labs (STTK)
NASDAQ·03/05 09:24
Lifecore Biomedical Signs New Agreement With Indomo For DT-001 In Acne Treatment
TipRanks·03/04 21:50
Lifecore, Indomo enter DT-001 development services agreement
Reuters·03/04 21:03
Lifecore Biomedical signs development services agreement with Indomo for DT-001 batches
Reuters·03/04 21:03
LIFECORE BIOMEDICAL SIGNS NEW AGREEMENT WITH INDOMO TO SUPPORT INNOVATIVE DRUG/DEVICE COMBINATION ACNE TREATMENT
Dow Jones·02/27 20:31
U.S. Earnings Preview: After Market Close Feb. 27
Reuters·02/17 12:05
Lifecore Biomedical Joins DCAT Week in New York
Dow Jones·02/13 20:31
U.S. Earnings Preview: After Market Close Feb. 13
Dow Jones·02/06 20:31
U.S. Earnings Preview: After Market Close Feb. 6
TipRanks·02/01 16:25
Lifecore Biomedical (LFCR) Receives a Buy from Craig-Hallum
Dow Jones·01/23 20:31
Earnings Preview: After Market Close Jan. 23
TipRanks·01/16 21:47
Lifecore Biomedical Adopts New Performance-Based Incentive Bonus Plan
Reuters·01/16 21:45
LIFECORE ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

Same Industry

Name/Symbol

Change%

Price

LFCR

MCK

BIIB

AMGN

SHPG

CELG-RT

LLY

CELG

TXMD

JNJ

ABBV

ZTS

GILD

NVO

BMY

PFE

ALXN

SNY

GCVRZ

Novartis

NVS

-0.53%

153.44

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.